Nothing Special   »   [go: up one dir, main page]

AU2001274022A1 - Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments - Google Patents

Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

Info

Publication number
AU2001274022A1
AU2001274022A1 AU2001274022A AU2001274022A AU2001274022A1 AU 2001274022 A1 AU2001274022 A1 AU 2001274022A1 AU 2001274022 A AU2001274022 A AU 2001274022A AU 2001274022 A AU2001274022 A AU 2001274022A AU 2001274022 A1 AU2001274022 A1 AU 2001274022A1
Authority
AU
Australia
Prior art keywords
amino
phenylhexane
phenylpentane
medicaments
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001274022A
Other versions
AU2001274022B2 (en
Inventor
Boris Chizh
Werner Englberger
Bernd Sundermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10025238A external-priority patent/DE10025238A1/en
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2001274022A1 publication Critical patent/AU2001274022A1/en
Application granted granted Critical
Publication of AU2001274022B2 publication Critical patent/AU2001274022B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001274022A 2000-05-22 2001-05-10 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments Ceased AU2001274022B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10025238A DE10025238A1 (en) 2000-05-22 2000-05-22 Use of substituted 1-amino-5-phenylpentan-3-ol and / or 1-amino-6-phenylhexan-3-ol compounds as medicaments
DE10025238.9 2000-05-22
PCT/EP2001/005349 WO2001089505A1 (en) 2000-05-22 2001-05-10 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

Publications (2)

Publication Number Publication Date
AU2001274022A1 true AU2001274022A1 (en) 2002-02-21
AU2001274022B2 AU2001274022B2 (en) 2004-10-14

Family

ID=7643080

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001274022A Ceased AU2001274022B2 (en) 2000-05-22 2001-05-10 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU7402201A Pending AU7402201A (en) 2000-05-22 2001-05-10 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU7402201A Pending AU7402201A (en) 2000-05-22 2001-05-10 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

Country Status (16)

Country Link
US (1) US6784175B2 (en)
EP (1) EP1289514B1 (en)
JP (1) JP2004509842A (en)
AR (1) AR029091A1 (en)
AT (1) ATE281158T1 (en)
AU (2) AU2001274022B2 (en)
CA (1) CA2406198A1 (en)
DE (2) DE10025238A1 (en)
ES (1) ES2231502T3 (en)
HU (1) HUP0301884A2 (en)
MX (1) MXPA02011410A (en)
NZ (1) NZ521439A (en)
PE (1) PE20011261A1 (en)
PT (1) PT1289514E (en)
UY (1) UY26718A1 (en)
WO (1) WO2001089505A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6856700B1 (en) * 2000-05-24 2005-02-15 Microsoft Corporation Palettized image compression
US9072662B2 (en) 2004-03-29 2015-07-07 Auris Medical Ag Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US8268866B2 (en) 2004-03-29 2012-09-18 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
US20060063802A1 (en) 2004-03-29 2006-03-23 Matthieu Guitton Methods for the treatment of tinnitus induced by cochlear excitotoxicity
JP2009509982A (en) * 2005-09-28 2009-03-12 アウリス メディカル アクチエンゲゼルシャフト Pharmaceutical composition for treating inner ear diseases
WO2012009258A2 (en) * 2010-07-13 2012-01-19 Edward Roberts Peptidomimetic galanin receptor modulators
ES2862673T3 (en) 2011-12-12 2021-10-07 Zilentin AG Treatment of tinnitus by modulating the NKCC1 chloride cotransporter in the auditory system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017637A (en) 1973-03-26 1977-04-12 American Home Products Corporation Benzylamine analgesics
US4155935A (en) * 1973-03-26 1979-05-22 American Home Products Corporation Benzylamine analgesics
US4366172A (en) * 1977-09-29 1982-12-28 The Upjohn Company 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use
IE913279A1 (en) * 1990-09-26 1992-04-08 Astra Ab (2-Thienyl)alkylamine Derivatives Having Neuroprotective¹Properties
DE19915601A1 (en) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use

Similar Documents

Publication Publication Date Title
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU763356C (en) Fused-ring compounds and use thereof as drugs
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU2609901A (en) Antimicrobial compositions and methods of use
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU7490900A (en) Chemical compounds and compositions and their use as cathepsin s inhibitors
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2002349705A1 (en) Azole compound and medicinal use thereof
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2002354410A1 (en) Triazole compound and medicinal use thereof
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
HUP0203900A3 (en) Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
AU2001272490A1 (en) Use of galiella lactone